Jam

Union Bankshares reported robust 2025 full-year growth, with net income up 26.5% to $11.1 million. Total assets grew 5.8% to $1.62 billion, driven by a significant 30.1% increase in investment securities. Despite a slight dip in Q4 net income, the bank strategically repositioned its portfolio and saw strong deposit growth. Net interest income rose 12.1%, though noninterest expenses increased due to investments in salaries and operations. Book value per share strengthened by 19.7%, and a quarterly dividend of $0.36 was declared.

Citizens Financial Group will present at the UBS Financial Services Conference on February 10, 2026. Don McCree and Ted Swimmer will discuss the company’s commercial banking operations. A live webcast will be available on the Citizens Investor Relations website.

Century Communities is launching Grants Landing, a new home community in Salisbury, NC, featuring one- and two-story homes starting in the $300,000s. The grand opening is January 23, with professionally decorated model homes and quick-move-in options available. The community offers over 200 homesites with diverse floor plans, modern features, and convenient access to employment centers and transportation. Century Communities also offers a streamlined online homebuying process.

Cabbacis has secured a new U.S. patent for its novel vaporizer pods, which contain blends of reconstituted tobacco and hemp. This patent, along with existing ones, strengthens the company’s intellectual property in the reduced-harm tobacco product sector. The pods aim to offer distinct taste profiles and utilize hemp as a non-intoxicating component. Cabbacis focuses on harm-reduction innovations, anticipating potential FDA regulations on nicotine content.

INEO Tech Corp. has issued a material breach notice to Bon Intelligence Inc. due to contractual violations, specifically regarding payment and reporting obligations. INEO Solutions has set cure periods and may terminate the license agreement if issues aren’t resolved. This dispute could impact approximately $206,625 in recognized revenue. Additionally, a separate reseller agreement with Bon Intelligence has been immediately terminated.

Valkea Resources strengthens its leadership with the appointments of Thomas Credland as President, Marc Turcotte as Director, and Dr. Charlotte Seabrook as Technical Advisor. These seasoned professionals bring extensive capital markets, corporate development, and geological discovery expertise. This strategic move aims to accelerate Valkea’s gold exploration efforts in Finland’s Central Lapland Gold Belt, leveraging their impressive track records in discovering and advancing significant mineral deposits.

Azincourt Energy has reported significant high-grade uranium intersections from its 2025 exploration program at the Harrier Project in Newfoundland & Labrador. Assay results confirmed robust mineralization, with surface samples reaching up to 6.28% U3O8. The project, spanning 49,400 hectares, is strategically located in a prospective uranium corridor. A 2026 drilling campaign will focus on the Snegamook deposit to define a resource estimate.

Dell has launched new Pro Education and Chromebook devices, built for durability and performance in educational settings. These AI-ready tools support modern learning, with rugged designs, extended battery life, and enhanced serviceability. Dell also expands its commitment with initiatives like Student TechCrew and the U.S. Presidential AI Challenge, aiming to equip students with essential digital and AI skills for future careers.

Visionary Holdings experienced a significant revenue decline of 46.2% in FY2025 due to shifts in real estate and education, while its new health and aesthetics ventures began generating revenue. The company incurred a net loss of $15.75 million, partly from asset impairment, but saw improved gross margins and reduced operating cash outflows. Facing negative working capital and loan defaults, Visionary Holdings is pursuing equity financing and debt restructuring to support its pivot toward health management and premium medical aesthetics, with early market testing in Asia.

KKR has deepened its investment in Sylvan, a global leader in fungal biotechnology, by leading a new funding round. This significant capital injection, with participation from new and existing investors like Novo Holdings, will fuel Sylvan’s global expansion. The funds are earmarked for scaling production, enhancing R&D, and entering new growth markets, particularly in Asia, solidifying Sylvan’s position as a key player in sustainable fungal solutions across food, health, agriculture, and materials.